APOLLOHOSP

APOLLO HOSPITALS ENTERPRISE

Large Cap BSE: 508869 NSE: APOLLOHOSP
₹4719.2
-2.65 (-0.06%)
As on 29 November, 2022 | 19:36

Apollo Hospitals Enterprise Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in APOLLO HOSPITALS ENTERPRISE

Start SIP

Apollo Hospitals Enterprise Share Price

Apollo Hospitals Enterprise Share Returns

  • Over 1 Month 3.33%
  • Over 3 Month 11%
  • Over 6 Month 22.2%
  • Over 1 Year -17.6%

Apollo Hospitals Enterprise Key Statistics

P/E Ratio 80.8
PEG Ratio -4.3
Market Cap Cr 67,855
Price to Book Ratio 11.5
EPS 45.5
Dividend 0.2
Relative Strength Index 62.29
Money Flow Index 77.79
MACD Signal 55.03
Average True Range 131.12

Apollo Hospitals Enterprise Investment Rating

  • Master Rating:
  • Apollo Hosps.Enterprise has an operating revenue of Rs. 15,232.03 Cr. on a trailing 12-month basis. An annual revenue growth of 39% is outstanding, Pre-tax margin of 11% is healthy, ROE of 18% is exceptional. The company has a reasonable debt to equity of 43%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 10% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 43 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Apollo Hospitals Enterprise Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1,7161,5301,4212,8462,8232,9952,410
Operating Expenses Qtr Cr 1,2631,1411,0892,4222,3842,6042,074
Operating Profit Qtr Cr 453388332424439391336
Depreciation Qtr Cr 9289105979496101
Interest Qtr Cr 58605862646468
Tax Qtr Cr 66-83401011038353
Net Profit Qtr Cr 279333154175186150116

Apollo Hospitals Enterprise Technicals

EMA & SMA

Current Price
4719.2
-2.65 (-0.06%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 4547.4
  • 50 Day
  • 4443.84
  • 100 Day
  • 4376.08
  • 200 Day
  • 4283.98
  • 20 Day
  • 4503.53
  • 50 Day
  • 4430.56
  • 100 Day
  • 4318.06
  • 200 Day
  • 4280.83

Apollo Hospitals Enterprise Resistance and Support

PIVOT
₹4724.65
Resistance
First Resistance 4766.05
Second Resistance 4810.25
Third Resistance 4851.65
RSI 62.29
MFI 77.8
MACD Single Line 55.03
MACD 86.51
Support
First Resistance 4680.45
Second Resistance 4639.05
Third Resistance 4594.86

Apollo Hospitals Enterprise Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 609,790 18,080,274 29.65
Week 952,390 27,457,415 28.83
1 Month 723,083 27,976,062 38.69
6 Month 619,084 23,432,329 37.85

Apollo Hospitals Enterprise Result Highlights

Apollo Hospitals Enterprise Synopsis

NSE-Medical-Hospitals

Apollo Hospitals is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 6098.30 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2022. Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035.
Market Cap 67,760
Sales 7,512
Shares in Float 10.21
No of funds 1277
Yield 0.25
Book Value 11.11
U/D Vol ratio 1.1
LTDebt / Equity 31
Alpha -0.09
Beta 0.99

Apollo Hospitals Enterprise

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 29.33%29.33%29.33%
Mutual Funds 8.82%7.64%5.94%
Insurance Companies 5.71%7.06%6.5%
Foreign Portfolio Investors 49.09%48.48%50.81%
Financial Institutions/ Banks 0.2%0.01%
Individual Investors 4.23%4.48%4.27%
Others 2.82%2.81%3.14%

Apollo Hospitals Enterprise Management

Name Designation
Dr. Prathap C Reddy Founder & Executive Chairman
Mrs. Preetha Reddy Executive Vice Chairperson
Mrs. Shobana Kamineni Executive Vice Chairperson
Mrs. Suneeta Reddy Managing Director
Mrs. Sangita Reddy Joint Managing Director
Mr. M B N Rao Independent Director
Mr. Vinayak Chatterjee Independent Director
Dr. Som Mittal Independent Director
Mrs. V Kavitha Dutt Independent Director
Dr. Murali Doraiswamy Independent Director
Mrs. Rama Bijapurkar Independent Director

Apollo Hospitals Enterprise Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Apollo Hospitals Enterprise Corporate Action

Date Purpose Remarks
2022-11-10 Quarterly Results
2022-08-11 Quarterly Results
2022-05-25 Audited Results & Dividend
2022-02-11 Quarterly Results
2021-11-12 Quarterly Results

Apollo Hospitals Enterprise MF Shareholding

Name Amount(cr)
SBI Nifty 50 ETF 151468
HDFC Balanced Advantage Fund Growth 49709
UTI Nifty 50 Exchange Traded Fund 39494
Axis Bluechip Fund Growth 36871
HDFC Flexi Cap Fund Growth 31686

About Company

Company Brief

Widely known for operating a nationwide legendary chain of hospitals, the Apollo group is a modern healthcare giant that also runs several diagnostic centres, pharmacies and telehealth clinics under its umbrella. Over the years, the group has forayed into other non-core healthcare domains like health insurance, medical colleges and medvarsity, nursing and hospital management, global projects consultancy and research. 
The prominent brands under its roof include Apollo Munich Health Insurance, Apollo Pharmacy, Life Studio, Apollo Spectra, and Apollo Cradle, besides Apollo Clinic and Hospitals.

History

Apollo Hospitals was founded by Dr Prathap C Reddy, with its first-ever branch established in Chennai in 1983 and inaugurated by the then president Shri Giani Zail Singh. In the 1980's it had declared its maiden dividend of 10% and established a branch in Hyderabad. Since then, it has set up numerous branches in New Delhi, Bangalore, Kolkata, Mumbai, Noida, Ahmedabad, and Bhubaneshwar, among other Indian cities. It also has a branch in Dhaka, Bangladesh.
One of its early trailblazing endeavours was telemedicine services in 2000 at Aragonda village in Chittoor, Andhra Pradesh. In 2012, 38% stake of the group's healthcare BPO segment was disposed off to Sutherland Global Services at a valuation of INR 225 crores. Further, in early 2020, the majority stake of its insurance subsidiary Apollo Munich Health Insurance was acquired by HDFC for INR 1,495.81 crores.
Over the years, the group has earned multiple international recognitions in healthcare standards, biotechnological breakthroughs and innovative medical care. It has 8 JCIA and 30 NABH (National Accreditation Board for Hospitals) accredited hospitals, not to mention its state-of-the-art speciality wings, including 25 Heart institutes, several cancer hospitals and organ transplant centres.

Board, Management and Auditors

Board of Directors

The board of directors manages the group in the parent company under the able leadership of founder chairman Dr Prathap Chandra Reddy - a Padma Bhushan and Padma Vibhushan awardee. The board consists of:

Executive Director - Prathap C. Reddy 

Dr Reddy is the visionary founder of the Apollo enterprise, responsible for ushering in an era of world-class medical facilities and treatments in India. He is the torchbearer of modern healthcare in this country and is the driving force behind the group's success.

Executive Vice Chairperson - Dr Preetha Reddy

A member of the founding family Dr Reddy is known for her immense contribution to the furtherance of the Apollo group and the betterment of the country through her philanthropic ventures and able governance.

 Executive Vice Chairperson - Ms Shobana Kamineni

Another member of the founding family has advocated the operation of integrated digital-first healthcare services in the country through Apollo 24/7. Presently Ms Kamineni leads the country's largest pharmacy chain, Apollo Pharmacy, with a countrywide network of over 4,000+ stores and 30,000+ employees.

Ms Suneeta Reddy -  Managing Director

Ms Reddy is at the forefront of the group's finance and strategy functions and serves on various subsidiaries' boards.

Dr Sangita Reddy- Joint Managing Director

As a joint MD, Dr Reddy spearheads the Global Healthcare service delivery and is an honourable member of the World Economic Forum.

Independent Directors

M B N Rao is the lead independent director, and Vinayak Chatterjee, Murali Doraiswamy, V Kavitha Dutt, and Som Mittal are eminent independent directors on the board who oversee the corporate governance of the company and look into the interest of the investors and public.

Auditors

The financials are audited by Deloitte Haskins & Sells LLP. It is one of the largest big4 accounting firm networks headquartered in England. They have been auditing the financials of the group from the financial year ending March 2017.

Market Capitalisation and Stock Information

Apollo Enterprise Ltd., went public in the year 1979. Consequently, it was listed in the NSE in January 1996, followed by BSE and several other exchanges. Since then, the stock has performed well and even stood out as the top performer in its peer groups in recent times. Let's look at some of the facts and figures:
●  The market cap stands at INR 51,895 crores, with the free float Market cap being INR 39,767.52 as of 31st May 2022.
●   The TTQ or Total Traded Quantity of its stock is 0.18 Lakhs.
●  The Face Value of shares is INR 5 each.
●  The stock is part of the S&P BSE 100 Index.

Shareholding Pattern

Till March 2022, the promoter holding has been 29.33%, with the remaining stake held by the public, including FIIs and DIIs being 70.67% of the total shares. Out of the total stake, FIIs held 50.81%, Other Domestic Institutions 6.51%, Mutual Funds 5.94%, and Retail and Other investors held 7.41% of the company's equity shares.

The top mutual funds that have invested more than 2% of their AUM in the stock are Nippon India Pharma Fund, IDFC Balanced Advantage Fund, LIC MF Large Cap Fund and Sundaram Services Fund.

Corporate Social Responsibility Information

Steered by Dr Reddy, the founder and chairman of the group Apollo has been an exemplar in philanthropic collaborations and endeavours. The group's Total Health Cycle philosophy is: to 'screen, diagnose, treat, educate, and empower.' It successfully runs 3 philanthropic and humanitarian programs that aim at the economic and social prosperity of the underprivileged.

Total Health Program

This CSR model aims to enhance the mental, physical, social, ecological and spiritual health of individuals and the community at large. It directs its activities toward the society's comprehensive welfare and is mostly concentrated in the rural areas of Andhra Pradesh and Telangana.

Billion Hearts Beating Foundation

This non-profit organisation which runs several charitable projects for the elderly, public servants and healthcare workers, contributes by way of medicine supply and organisation of free healthcare camps for the beneficiaries. It also operates some critical care units in areas of public interest.

The SACHi Initiative

SACHi, on the other hand, is a child-focused non-profit initiative that fights for causes such as equal rights and quality healthcare for children. Over the years, it has provided free heart treatments, medicines and supplements to numerous children's homes and orphanages. It continues to pledge its services to touch the lives of many more children in the times to come.

Financial Information

Top Line

Over the last 5 years, the audited financial statements show a leap of INR 6420 crores in the Apollo group's total revenue. It was INR 8243 crores in 2018, INR 9617 crores in 2019, INR 11247 crores in 2020, INR 10560 crores in 2021 and INR 14663 crores in the year ending 2022. The revenue can be segregated as - 56% from core healthcare services and 9% from Apollo Health and Lifestyle, including Clinics, Diagnostic Centres, Dental, Dialysis and Fertility centres. Another 35% comes from the Pharmacy Distribution.

Bottom Line

On the other hand, the profit recorded has grown exponentially from Rs. 117 crores by a whopping 802.5% over the course of 5 years. The highest growth can be seen in the financial year 2021-22, when the bottom line grew 10 times. This can be attributed to a significant increase in revenue with a reduction in selling, general and administrative expenses.

Net Worth

The net worth of Apollo Hospitals Enterprise Ltd has stayed fairly the same during the 3 years from 2018 to 2020. From the year 2021, it has grown by INR 1042.65 crores and has reached INR 5645.15 crores in the financial year ending 2022. 

Apollo Hospitals Enterprise FAQs

What is Share Price of Apollo Hospitals Enterprise ?

Apollo Hospitals Enterprise share price is ₹4719 As on 29 November, 2022 | 19:22

What is the Market Cap of Apollo Hospitals Enterprise ?

The Market Cap of Apollo Hospitals Enterprise is ₹67854.9 Cr As on 29 November, 2022 | 19:22

What is the P/E ratio of Apollo Hospitals Enterprise ?

The P/E ratio of Apollo Hospitals Enterprise is 80.8 As on 29 November, 2022 | 19:22

What is the PB ratio of Apollo Hospitals Enterprise ?

The PB ratio of Apollo Hospitals Enterprise is 11.5 As on 29 November, 2022 | 19:22

Who is the CEO of Apollo Hospitals Enterprise?

Dr. Prathap C. Reddy is the founder and chairman of Apollo Hospitals Enterprise.

What is the ROE of Apollo Hospitals Enterprise?

The ROE of Apollo Hospitals Enterprise is 3% which is fair but needs improvement.

When was Apollo Hospitals Enterprise founded?

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned as the architect of modern healthcare in India.

What is the stock price CAGR of Apollo Hospitals Enterprise?

The stock price CAGR of Apollo Hospitals Enterprise for 10 Years is 23%, 5 Years is 33%, 3 Years is 55%, 1 Year is 98%.

Is it a good time to invest in Apollo Hospital Enterprise?

Apollo Hospital Enterprise has an operating revenue of Rs. 13,105.07 Cr. on a trailing 12-month basis. Annual revenue de-growth of -6% needs improvement, Pre-tax margin of 2% needs improvement. The company has a debt to equity of 54%, which is a bit higher. Several analysts have a Buy rating on the stock.

How to buy Apollo Hospitals Enterprise Ltd. shares?

You can easily buy the shares of Apollo Hospitals Enterprise Ltd., by registering at 5Paisa and by setting up a Demat Account in your name.
 

Q2FY23